홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Pyridine → HCID 178488195, 화합물

HRID 432413
인쇄

반응식

HRID 432413 반응식
[C:1]1([C@H:7]([CH3:12])[CH2:8]C(O)=O)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[C:13](Cl)(=[O:17])C(Cl)=O.N[C:20]1[CH:25]=[CH:24][C:23]([C:26]2[C:34]3[C:29](=[N:30][CH:31]=[N:32][C:33]=3[NH2:35])[N:28]([C@H:36]3[CH2:41][CH2:40][C@H:39]([N:42]4[CH2:47][CH2:46][N:45]([CH3:48])[CH2:44][CH2:43]4)[CH2:38][CH2:37]3)[N:27]=2)=[CH:22][C:21]=1[O:49][CH3:50].C(OCC)(=O)C.[N:57]1C=CC=CC=1>ClCCl.CN(C=O)C>[C:1]1([C@@H:7]([CH3:12])[CH2:8][NH:57][C:13](=[O:17])[C:20]2[CH:25]=[CH:24][C:23]([C:26]3[C:34]4[C:29](=[N:30][CH:31]=[N:32][C:33]=4[NH2:35])[N:28]([C@H:36]4[CH2:41][CH2:40][C@H:39]([N:42]5[CH2:47][CH2:46][N:45]([CH3:48])[CH2:44][CH2:43]5)[CH2:38][CH2:37]4)[N:27]=3)=[CH:22][C:21]=2[O:49][CH3:50])[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 1049PyridineHCID 8857Ethyl AcetateHCID 65578Oxalyl chlorideHCID 852992(3R)-3-phenylbutanoic acidHCID 178488198HCID 178488198, 화합물

생성물 1

HCID 178488195HCID 178488195, 화합물수율 64%

시약·촉매·용매 2

HCID 6228Dimethylformamide촉매HCID 6344Dichloromethane용매2회

실험 절차

To (3R)-3-phenylbutanoic acid (376 mg, 2.29 mmol) in dichloromethane (7 mL) was added oxalyl chloride (2 mL, 22.9 mmol) and DMF (1 drop). The reaction mixture was stirred overnight. Solvent was evaporated and the residue was dissolved in dichloromethane (3 mL). The dichloromethane solution was added to a solution of trans-3-(4-amino-3-methoxyphenyl)-1-[4-(4-methylpiperazino)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine (448 mg, 1.026 mmol) in pyridine (6 mL) at 0° C. After 2 hours, the reaction mixture was poured to ethyl acetate (60 ml) and the solid as collected by filtration. Water was then added to the solid and the pH of the solution was adjusted to 10 with sodium hydroxide (1.0N). The aqueous was extracted with dichloromethane. The combined organic layer was washed with water then brine, dried over MgSO4, filtered and evaporated. The residue was purified by flash column chromatography using dichloromethane/methanol (80:20) as mobile phase to give trans-N1-[(2R)-2-phenylpropyl]-4-{4-amino-1-[4-(4-methylpiperazino)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxybenzamide (383 mg, 64%). 1H NMR (CDCl3) δ 1.40 (d, J=6.96, 3H), 1.57 (m, 2H), 2.08-2.21 (m, 6H), 2.30 (s, 3H), 2.50 (m, 5H), 2.63-2.74 (m, 6H), 3.40 (m, 1H), 3.88 (s, 3H), 4.74 (m, 1H), 5.69 (bs, 2H), 7.16-7.34 (m, 7H), 7.66 (s, 1H), 8.34 (s, 1H), 8.49 (d, J=8.21, 1H).

후처리

  1. customSolvent was evaporated
  2. dissolutionthe residue was dissolved in dichloromethane (3 mL)
  3. waitAfter 2 hours
  4. filtrationthe solid as collected by filtration
  5. additionWater was then added to the solid
  6. extractionThe aqueous was extracted with dichloromethane
  7. washThe combined organic layer was washed with water
  8. dry with materialbrine, dried over MgSO4
  9. filtrationfiltered
  10. customevaporated
  11. customThe residue was purified by flash column chromatography

출처 및 근거

ORD 기록
ord-467258d7343346eda7b8f51d658c9429
출처 데이터셋
uspto-grants-2003_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06660744B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트